Miami Cancer Institute Immunotherapies Summit for Hematologic Malignancies, Seventh Annual
Agenda
Friday, March 6 - 6.5 Cat. 1
| 7:30 - 8:30 a.m. | Registration, Breakfast and Visit Exhibits |
| 8:30 - 8:45 a.m. | Welcome and Introductions Guenther Koehne, M.D., Ph.D. |
| Multiple Myeloma | |
| 8:45 - 9:05 a.m. | Maintenance Therapy Post Autologous Transplants: Does MRD status Affect the Treatment Choice? Saad Usmani, M.D. |
| 9:05 - 9:25 a.m. | Redirecting Therapies for Relapsed/Refractory Multiple Myeloma by CAR T and Bites Adam Cohen, M.D. |
| 9:25 - 9:45 a.m. | Integration of CellMods into Treatment Approaches for Multiple Myeloma Paul Richardson, M.D. |
| 9:45 - 10:05 a.m. | Insights on Adapting Treatments for Multiple Myeloma with New Immunotherapies in Countries with Limited or Intermediate Resources Patricio Duarte, M.D. |
| 10:05 - 10:25 a.m. | How to Treat AL Amyloidosis in 2026 Heather Landau, M.D. |
| 10:25 - 10:45 a.m. | Panel Discussion Usmani, Cohen, Richardson, Duarte, Landau |
| 10:45 - 11:05 a.m. | Break and Exhibits |
| B- and T-Cell Malignancies | |
| 11:05 - 11:25 a.m. | Novel Therapies in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) Matthew Matasar, M.D. |
| 11:25 - 11:45 a.m. | Novel therapies in Chronic Lymphocytic Leukemia (CLL) Craig Sauter, M.D. |
| 11:45 - 12:05 p.m. | How to Treat T-Cell Lymphoma in 2026 Steven M. Horwitz, M.D. |
| 12:05 - 12:20 p.m. | Panel Discussion Matasar, Sauter, Horwitz |
| 12:20 - 12:50 p.m. | Lunch and Exhibits |
| 12:50 - 1:20 p.m. | Product Theater |
| Acute Leukemia | |
| 1:20 - 1:40 p.m. | Overcoming Treatment Resistance in T-All: Translation to the Clinic Wendy Stock, M.D. |
| 1:40 - 2:00 p.m. | AML 2026: Is 7+3 Still The Standard of Care? Richard Stone, M.D. |
| 2:00 - 2:20 p.m. | Updates on Targeted Therapies in Acute Myeloid Leukemia Eytan Stein, M.D. |
| 2:20 - 2:40 p.m. | LYT-200 An Anti-Galectin 9 Antibody, for Treatment of AML/High-risk Aleksandra Filipovic, M.D., Ph.D. |
| 2:40 - 2:55 p.m. | Panel Discussion Stock, Stone, Stein, Filipovic |
| 2:55 - 3:10 p.m. | Break and Exhibits |
| Myeloproliferative Disorders | |
| 3:10 - 3:30 p.m. | Novel Therapeutic Strategies in Myelofibrosis Raajit K. Rampal, M.D., Ph.D. |
| 3:30 - 3:50 p.m. | The Role of Menin Inhibitors in Myelofibrosis Firas El Chaer, M.D. |
| 3:50 - 4:10 p.m. | Myelofibrosis: Who to Transplant and Who Not to Transplant? Nicolaus Kroeger, M.D. |
| 4:10 - 4:25 p.m. | Panel Discussion Rampal, El Chaer, Kroeger |
| 4:25 - 4:35 p.m. | Closing Remarks/Adjourn Guenther Koehne, M.D., Ph.D. |
| 4:35 - 5:05 p.m. | Product Theater |
Saturday, March 7 - 3.5 Cat. 1
| 8:00 – 8:30 a.m. | Registration and Breakfast |
| Updates on CAR Therapies | |
| 8:30 – 8:50 a.m. | Next Steps in CAR T-Cell Therapies Michel Sadelain, M.D. |
| 8:50 – 9:10 a.m. | Optimizing CAR T-Cell Homing via GPS Robert Sackstein, M.D., Ph.D. |
| 9:10 – 9:30 a.m. | Do CARs Always Have to be T-Cells? Paul Lin, M.D. |
| 9:30 – 9:45 a.m. | Panel Discussion Sadelain, Sackstein, Lin |
| 9:45 – 10:00 a.m. | Break and Visit Exhibits |
| 10:00 – 10:30 a.m. | Product Theater |
| Allogeneic Stem Cell Transplants | |
| 10:30 – 10:50 a.m. | Myelodysplastic Syndrome (MDS): Who to Transplant and Who Not to Transplant? Mary M. Horowitz, M.D. |
| 10:50 – 11:10 a.m. | The Role of Intestinal Microbiome in Cancer Immunotherapy Marcel R.M. van den Brink, M.D., Ph.D. |
| 11:10 – 11:30 a.m. | Novel Approaches to GVHD Prevention and Therapy Corey Cutler, M.D. |
| 11:30– 11:45 a.m. | Break and Visit Exhibits |
| 11:45 – 12:05 p.m. | Updates on Allo BMT Robert Soiffer, M.D. |
| 12:05 – 12:25 p.m. | Redefining prevention—what's next for GVHD prophylaxis? Leo Luznik, M.D. |
| 12:25 – 12:45 p.m. | Is it time for post-transplant maintenance therapies in AML? Guenther Koehne, M.D., Ph.D. |
| 12:45 – 1:05 p.m. | Panel Discussion Horowitz, van den Brink, Cutler, Soiffer, Luznik, Koehne |
| 1:05 – 1:15 p.m. | Closing Remarks and Adjourn |
NOTE: Schedule subject to change.

JW Marriott Miami
1109 Brickell Avenue
Miami, Florida 33131
United States
+1 (305) 329-3500
About the Venue
The JW Marriott Miami is located in the heart of Brickell, Miami's trendy destination for dining, shopping, and nightlife and is located a short walk away from the popular shopping and entertainment destination, Brickell City Centre. Guests are not far from all that Miami has to offer including the Perez Art Museum, Frost Science Museum, Kaseya Center (home of the Miami Heat), Adrienne Arsht Center, Port of Miami, South Beach, Coral Gables, Coconut Grove and Miami International Airport.
Rooms Rates and Highlights
- 399.00 USD per night - Last Day to Book: Thursday, February 12, 2026
- 24-hour room service - Free Wi-Fi for Marriott Bonvoy members - Complimentary fitness center access - Spa - Pool - Business Center
Travel Information
The drive time between the JW Marriott Miami and Miami International Airport (MIA) is around 20 minutes and covers a distance of around 8.2 miles.
Services + Amenities
Relax with a facial or full body massage by an expert therapist at Salus Spa. Afterward, continue to unwind in the warmth of the Miami sun at the JW Marriott Miami's stainless steel sky pool.
Adjacent to The Spa is our Fitness Studio, the perfect escape for an energizing workout, featuring state-of-art equipment and free weights.
Dining
Isabela's
With its natural light and views of Brickell Ave, Isabela's is the perfect place to start the day.
La Terraza Cafe & Bar
With its Plasma TV's and LED Screens tuned to popular sporting events & delicious casual fare served at lunch, dinner, and weekend Brunch makes La Terraza the ideal place to unwind with friends and family.
Downtown Miami and Brickell
Greater Miami is synonymous with beautiful beaches and towering palm trees - but in its urban center, it is the cityscape of glittering skyscrapers over Biscayne Bay that gets all the attention. Diverse, dynamic and densely populated, Downtown Miami and the adjoining Brickell area is a hub of international finance, dining, arts and entertainment that no visitor should miss.
Symposium Director

Deputy Director and Chief of Stem Cell Transplantation
Hematologic Oncology and Benign Hematology
Baptist Health, Miami Cancer Institute
Miami, Florida
Faculty
Associate Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Associate Professor of Hematology
Instituto Universitario CEMIC
Bueno Aires, Argentina

Chief of Leukemia and
Medical Director of Infusion
Baptist Health, Miami Cancer Institute
Miami, Florida

Department of Surgery and Cancer
Imperial College of London
London, England

Robert A. Uilhlein, Jr. Chair in Hematologic Research
Deputy Cancer Center Director
Medical College of Wisconsin
Scientific Director Emeritus Center for International Blood and Marrow Transplant Research
Milwaukee, Wisconsin

Lymphoma Specialist and Cellular Therapist
Memorial Sloan Kettering Cancer Center
New York, New York

Professor of Medicine
Medical Director of the Department of Stem Cell Transplantation
University Medical Center
Hamburg-Eppendorf
Hamburg, Germany

Hematology Oncology
Bone Marrow Transplant Specialist and Cellular Therapists
Memorial Sloan Kettering Cancer Center
New York, New York

Assistant Professor of Medicine
Multiple Myeloma and Cellular Therapy
MD Anderson Cancer Center
Houston, Texas

Professor of Oncology
Johns Hopkins Medicine
Baltimore, Maryland

Chief, Division of Blood Disorders
Rutgers CINJ and RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey

Associate Member and Clinical Director
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York

Clinical Program Leader and Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Tenured – Professor
Department of Cellular and Molecular Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida

Director of the Columbia Initiative in
Cell Engineering and Therapy
Director of Cancer Cell Therapy Initiative
Herbert and Florence Irving Professor of Medicine
Columbia University
New York, New York

Hematology and Medical Oncology
Director, Blood and Marrow Transplant Program
Cleveland Clinic Main Campus
Cleveland, Ohio

Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Assistant Attending Physician
Director, Program for Drug Development in Leukemia
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Anjuli Seth Nayak
Professor of Leukemia Research
University of Chicago
Chicago, Illinois

Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Chief of Myeloma Service at
Memorial Sloan Kettering Cancer Center
Professor at Weill Cornell Medical College
New York, New York

President of City of Hope Los Angeles
National Medical Center
Los Angeles, California
NOTE: Faculty subject to change.

Facebook
X
LinkedIn
Forward